Inivata

📍 Durham, United States🗓 Founded 2014👥 64 employees💰 Last funded Apr 2020
Biotechnology Research🌐 inivata.com
Website LinkedIn
Inivata is a leader in liquid biopsy. Its InVision® platform unlocks essential genomic information from a simple blood test to transform the care of cancer patients. The Company’s technology is based on pioneering research from the Cancer Research UK Cambridge Institute, University of Cambridge and backed by multiple high calibre publications. Its lead product, InVisionFirst™-Lung, is commercially available and provides molecular insights that enable clinicians to make more informed treatment decisions for NSCLC patients. Inivata is partnering with pharmaceutical and biotechnology companies on InVisionFirst-Lung and its wider platform, which is applicable to a range of cancer types. The Company has a CLIA laboratory in Research Triangle Park, NC and R&D laboratories in Cambridge, UK. For more information, please go to www.inivata.com. Follow us on Twitter @Inivata. For more information, please go to www.inivata.com. Follow us on Twitter @Inivata.
6
Total investors
4
Early stage
1
Mid stage
1
Late stage
2014
Founded

Investors

6 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
United Kingdom
3
Ireland
2
Switzerland
1
Investor activity2014–2020 · investors recorded per year
201442019120201
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Inivata?
Inivata has 6 investors on record on gritt.io, including 4 early-stage backers, 1 mid-stage and 1 late-stage investors.
When did Inivata last raise funding?
The most recent investment in Inivata recorded on gritt.io was in April 2020.
When was Inivata founded?
Inivata was founded in 2014.
What industry is Inivata in?
Inivata operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Inivata based?
Inivata is headquartered in Durham, United States.